Tectonic Therapeutic, Inc. 4

Chief Scientific Officer Peter McNamara exercised options for 43 shares of Tectonic Therapeutic, Inc. common stock at $14.71 and sold 43 shares at $35.00 on August 12, 2026 under a 10b5-1 plan.

On August 12, 2026, Chief Scientific Officer Peter McNamara executed an option exercise and immediate sale of a small number of shares of Tectonic Therapeutic, Inc. common stock pursuant to a Rule 10b5-1 trading plan. He exercised employee stock options for 43 shares at $14.71 per share, acquiring common stock, and then sold 43 shares of common stock at $35.00 per share, resulting in an incremental net gain but no material change in his overall equity position. After these transactions, he directly owned 55,285 shares of common stock, indicating this was a routine, de minimis liquidity event rather than a significant directional trade.

Filing Facts

CIK

1681087

Ticker

TECX

Form

4

Source Type

fda

Accession

0002023255-26-000007

Alert Tier

5